These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 484913)

  • 1. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ancrod: clinical indications and methods of use.
    Wright JG; Geroulakos G
    Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of severe intermittent claudication by controlled defibrination.
    Dormandy JA; Goyle KB; Reid HL
    Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of plasma fibrinogen in vascular surgery.
    Postlethwaite JC
    Ann R Coll Surg Engl; 1976 Nov; 58(6):457-64. PubMed ID: 984690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
    Dormandy JA
    Angiology; 1981 Oct; 32(10):710-4. PubMed ID: 7325406
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled defibrination in the treatment of peripheral vascular disease.
    Dormandy JA; Reid HL
    Angiology; 1978 Jan; 29(1):80-8. PubMed ID: 343654
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E
    Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg.
    Lowe GD; Dunlop DJ; Lawson DH; Pollock JG; Watt JK; Forbes CD; Prentice CR; Drummond MM
    Angiology; 1982 Jan; 33(1):46-50. PubMed ID: 7036801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A report on the use of Arvin in patients with pre-gangrene of the lower limb.
    Humphreys WV; Walker A; Charlesworth D
    Br J Surg; 1977 Jan; 64(1):31-3. PubMed ID: 831951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous ancrod after operation for fractured hip--a dose-ranging and feasibility study.
    Lowe GD; Morrice JJ; Fulton A; Forbes CD; Prentice CR; Barbenel JC
    Thromb Haemost; 1978 Aug; 40(1):134-43. PubMed ID: 725844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in blood flow through a critical arterial stenosis by defibrination with ancrod.
    Barrie WW; Schenk WG
    Arch Surg; 1976 May; 111(5):561-3. PubMed ID: 1267605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of blood viscosity on blood flow in the experimental saphenous flap model.
    Awwad AM; White RJ; Lowe GD; Forbes CD
    Br J Plast Surg; 1983 Jul; 36(3):383-6. PubMed ID: 6860871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy in intermittent claudication: an objective assessment of the effects of three drugs on patients with intermittent claudication.
    Mashiah A; Patel P; Schraibman IG; Charlesworth D
    Br J Surg; 1978 May; 65(5):342-5. PubMed ID: 647201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hydroxyethylrutoside (HR) on peripheral blood flow: a preliminary report.
    Fitzgerald DE; Butterfield WJ; Keates JS; Hodges M
    Bibl Anat; 1969; 10():600-5. PubMed ID: 5407421
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology.
    Forbes CD; Barbenell J; Prentice CR
    Haemostasis; 1976; 5(6):348-54. PubMed ID: 1017726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defibrinating agents: effects on blood rheology, blood flow and vascular diseases in controlled studies.
    Lowe GD
    Bibl Haematol; 1981; (47):247-51. PubMed ID: 7039612
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
    Heidrich H
    Med Klin; 1978 May; 73(21):798-800. PubMed ID: 651769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.